FDA.reportPublic FDA data

ARMODAFINIL

Product NDC
59651-047
Requested package NDC
59651-047-30
11-digit product format
596510047
Labeler code
59651
Product ID
59651-047_a75b2046-1bc3-4ada-a593-7300665acdd6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ARMODAFINIL
Dosage form
TABLET
Route
ORAL
Labeler
AUROBINDO PHARMA LIMITED
Application
NDA021875
Marketing category
NDA
Marketing start
2016-08-03
Marketing end
2023-05-31
Substance
ARMODAFINIL
Active strength
200 mg/1
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage59651-04759651-047-30DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021875-001NUVIGILARMODAFINIL50MGTABLET / ORALABRLD2007-06-15
N021875-002NUVIGILARMODAFINIL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2009-03-26
N021875-003NUVIGILARMODAFINIL150MGTABLET / ORALABRLD2007-06-15
N021875-004NUVIGILARMODAFINIL250MGTABLET / ORALABRLD, RS2007-06-15
N021875-005NUVIGILARMODAFINIL200MGTABLET / ORALABRLD2009-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
N021875-001AB
N021875-003AB
N021875-004AB
N021875-005AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N021875-001NUVIGIL50MGTABLET / ORALABRLD2007-06-15a50c72e98297…
2026-08-01 22:54:322026-06N021875-002NUVIGIL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD2009-03-26a50c72e98297…
2026-08-01 22:54:322026-06N021875-003NUVIGIL150MGTABLET / ORALABRLD2007-06-15a50c72e98297…
2026-08-01 22:54:322026-06N021875-004NUVIGIL250MGTABLET / ORALABRLD, RS2007-06-15a50c72e98297…
2026-08-01 22:54:322026-06N021875-005NUVIGIL200MGTABLET / ORALABRLD2009-03-26a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N021875-001AB1a50c72e98297…
2026-08-01 22:54:322026-06N021875-003AB1a50c72e98297…
2026-08-01 22:54:322026-06N021875-004AB1a50c72e98297…
2026-08-01 22:54:322026-06N021875-005AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NuvigilARMODAFINILGolden State Medical Supply, Inc.3dd49302-f757-d945-e063-6294a90afcba2025-09-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
NuvigilARMODAFINILApotex Corp.a69631d0-1263-769e-b232-4ab9160e0fa32025-08-18Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
ARMODAFINILARMODAFINILDirectRxddd06dab-0855-5b4e-e053-2a95a90a5e672025-01-22Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
ARMODAFINILARMODAFINILdirect rxb1ba1cdd-cf57-7a8c-e053-2a95a90a2c192025-01-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
ArmodafinilARMODAFINILQuality Care Products LLC98338994-7818-4b86-ae98-cd08fa7008792024-12-17Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
ArmodafinilARMODAFINILTeva Pharmaceuticals USA, Inc.b3cac300-c3d2-4189-a410-2aaf3773c0902023-01-31Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
ArmodafinilARMODAFINILSandoz Inca3341ec8-1ad4-49e2-922b-13d1b30c8c1d2023-01-31Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875
NuvigilARMODAFINILCephalon, LLCd878aed0-ddbf-8fa1-abf7-d3e4802608452022-12-31Warnings, Adverse reactionsExact identifier
application applno (NDA): 021875
application number: NDA021875

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59651-047-30EA - Each59651-047c81519db-9fb0-4003-b901-afd4f8a6ca2d12016-09-02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
59651-047-305965100473030 TABLET in 1 BOTTLE (59651-047-30) 30 tablet2016-08-032023-05-31NoNoCurrent